At a glance
ClinicalIndex Comparison RecordN/ACompleted· 98 enrolled
Drug / intervention
elladrug
Likely dose
ella 30mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective Multicenter Observational Study to Assess Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella
In Brief
An observational study evaluating ella for Emergency Contraception. Completed, enrolled 98 participants across 1 site.
Detailed Summary
The study is aimed at assessing the clinical follow-up and the outcomes of pregnancies exposed to ella, whether due to failure of the emergency contraception or inadvertent exposure during pregnancy.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsEmergency Contraception
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedApr 2012
Enrollment StartNov 2014
Primary CompletionJun 2018
TodayJul 2026
First PostedApr 3, 2012
Enrollment StartNov 18, 2014
Primary CompletionJun 29, 2018
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 14.2 years ago
Interventions
elladrug
ella, single intake, tablet 30mg